MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Flex Pharma Company Profile (NASDAQ:FLKS)

Consensus Ratings for Flex Pharma (NASDAQ:FLKS) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $27.20 (118.83% upside)

Analysts' Ratings History for Flex Pharma (NASDAQ:FLKS)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Roth CapitalLower Price Target$27.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015HC WainwrightReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015JMP SecuritiesInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha